Evidence map›Paper›PMID 28515219›Full record

ArticleJournal of clinical microbiology2017

A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate.

Erin Beckman, Ilaria Saracino, Giulia Fiorini, Courtney Clark, Vladimir Slepnev, Denise Patel, Clarissa Gomez, Reddy Ponaka, Vecheslav Elagin, Dino Vaira

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 71 citations in OpenAlex.

  1. New fecal test for non-invasiveWorld journal of gastroenterology · 2018
    Trial
  2. Article
  3. Resistance to Clarithromycin and Fluoroquinolones inAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Overcoming antibiotic-resistantWorld journal of gastroenterology · 2025
    Review
  5. Article
  6. Clinical evaluation of a novelFrontiers in cellular and infection microbiology · 2025
    Observational
  7. Clinical evaluation of personalizedFrontiers in cellular and infection microbiology · 2025
    Observational
  8. Molecular tools of antibiotic resistance forFrontiers in gastroenterology (Lausanne, Switzerland) · 2024
    Review
  9. Article
  10. Antibiotic Resistance, Susceptibility Testing and Stewardship inInternational journal of molecular sciences · 2023
    Review
  11. Diagnosis and Treatment ofDiagnostics (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Detection and Treatment ofGastroenterology research and practice · 2022
    Review
  17. Methods for detection of Helicobacter pylori from stool sample: current options and developments.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Review
  18. Diagnosis ofDiagnostics (Basel, Switzerland) · 2021
    Review
  19. What Is New inJournal of clinical medicine · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Erin BeckmanMeridian Bioscience, Inc., Cincinnati, Ohio, USA.
Ilaria SaracinoDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Giulia FioriniDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Courtney ClarkMeridian Bioscience, Inc., Cincinnati, Ohio, USA.
Vladimir SlepnevMeridian Bioscience, Inc., Cincinnati, Ohio, USA.
Denise PatelMeridian Bioscience, Inc., Cincinnati, Ohio, USA.
Clarissa GomezMeridian Bioscience, Inc., Cincinnati, Ohio, USA.
Reddy PonakaMeridian Bioscience, Inc., Cincinnati, Ohio, USA.
Vecheslav ElaginMeridian Bioscience, Inc., Cincinnati, Ohio, USA.
Dino VairaDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy berardino.vaira@unibo.it.
Meridian Bioscience (United States) · USUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clarithromycin-based regimens are commonly used as a first-line therapy for

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsClarithromycinDNA, BacterialFecesHelicobacter InfectionsHelicobacter pyloriHumansMolecular Diagnostic TechniquesPolymerase Chain ReactionSensitivity and SpecificityAnti-Bacterial AgentsClarithromycinDNA, Bacterialantibiotic resistanceclarithromycinclarithromycin resistanceHelicobacter pyloripolymerasesstoolstool PCR test

Identifiers

PMID28515219
PMCPMC5527417
OpenAlexW2614404918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.